CLINICAL_TRIALS
trial_result
· 2019-09-12
Clinical Trial Update: A Comparison of Two Doses of Pemetrexed in Patients Who Have Lung Cancer [Phase 3]
Summary
A Phase 3 trial comparing two doses of pemetrexed in non-small cell lung cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED